Liver Transplant Requirements: Who Qualifies and How the Process Works

If your doctor has mentioned liver transplant — or if you've been wondering whether you might need one — the first thing you probably want to know is whether you'd qualify. The answer involves more than just how sick your liver is. Transplant eligibility is a comprehensive assessment of your liver disease severity, your overall health, your psychosocial readiness, and your likelihood of surviving the surgery and thriving afterward.

This guide walks through the complete picture: who qualifies, what the evaluation involves, how the MELD score determines your priority, what can disqualify you, how exception points work for conditions the MELD doesn't capture, and what the living-donor option looks like.

⚡ Know your scores

Use the free MELD & Clinical Score Calculator to check your MELD, MELD-Na, and MELD 3.0 scores instantly. Or upload your lab report — LiverTracker calculates and tracks your scores automatically with every upload.

The three main reasons people need a liver transplant

Liver transplantation is considered for three broad categories of patients. Understanding which category you fall into shapes the entire conversation with your transplant team:

1. Chronic liver disease with decompensation

This is the most common reason. You have cirrhosis that has progressed to the decompensated stage — meaning your liver can no longer maintain its critical functions, and complications have developed. The specific complications that typically trigger transplant evaluation include recurrent or refractory ascites that doesn't respond to diuretics, repeated episodes of hepatic encephalopathy despite lactulose and rifaximin, variceal bleeding that can't be controlled with endoscopic therapy and beta-blockers, hepatorenal syndrome (kidney failure caused by liver disease), and progressive jaundice and liver failure reflected in a rising MELD score.

The causes of cirrhosis leading to transplant include alcohol-related liver disease (now the leading indication for transplant in the US), NASH/MASLD (the fastest-growing indication), hepatitis C (declining due to effective antiviral treatment), hepatitis B, autoimmune hepatitis, primary biliary cholangitis (PBC), primary sclerosing cholangitis (PSC), and other less common causes.

2. Liver cancer (hepatocellular carcinoma)

Patients with HCC confined to the liver may qualify for transplant even if their liver function (and therefore their MELD score) is relatively preserved. This is because transplant treats both the cancer and the underlying cirrhosis simultaneously — removing the entire diseased organ eliminates the cancer and the soil it grew in.

Eligibility for HCC-related transplant is defined by the Milan criteria: a single tumor 5 cm or smaller, or up to 3 tumors each 3 cm or smaller, with no evidence of vascular invasion or spread beyond the liver. Patients meeting Milan criteria receive MELD exception points (since their MELD may be low despite having cancer), which raises their priority on the waiting list. Patients initially outside Milan criteria may be "downstaged" with locoregional therapies (ablation, chemoembolization) and then become eligible.

3. Acute liver failure

Sudden, severe liver failure in someone without preexisting liver disease — typically from acetaminophen overdose, drug reactions, viral hepatitis, or autoimmune flares — can necessitate emergency transplant. These patients are classified as Status 1A on the waiting list, which gives them the highest priority nationwide. Status 1A means the patient's life expectancy is measured in hours to days without a transplant. Less than 1% of transplant candidates are in this category at any given time.

The MELD score: how transplant priority works

In the United States, transplant allocation for adult patients is determined by the MELD-Na score — a number from 6 to 40 calculated from bilirubin, INR, creatinine, and sodium. The sicker your liver (higher MELD), the higher your priority for receiving a deceased-donor organ.

The system is designed around one principle: the sickest patients get organs first. When a liver becomes available, it's offered to the highest-MELD patient in the area who is a compatible match. If no suitable recipient is found locally, the offer expands to wider geographic circles.

The median MELD at transplant varies dramatically by region — from about 19 in some areas to 36 in the most competitive urban centers like New York and Los Angeles. This geographic variation means that where you live significantly affects how long you wait and at what MELD you're likely to receive an offer.

Read the full breakdown: MELD Score Ranges: What Each Number Means.

The transplant evaluation: what happens before you're listed

Getting listed for transplant is not a single appointment — it's a comprehensive evaluation that typically takes 2–3 months and involves multiple specialists, tests, and committee reviews. The goal is to determine two things: does this patient need a transplant, and can this patient survive and benefit from it?

Medical evaluation

The medical workup is extensive. Your transplant center will typically perform or require complete blood work (liver panel, kidney function, coagulation, blood type, viral serology, metabolic panel, tumor markers), cardiac evaluation (echocardiogram, stress test, and sometimes cardiac catheterization — the heart must be strong enough for major surgery), pulmonary function testing (lung capacity must be adequate for surgery and recovery), cross-sectional imaging (CT or MRI of the abdomen to assess liver anatomy, portal vasculature, and screen for cancer), upper endoscopy (to evaluate for varices), cancer screening (mammogram, colonoscopy, pap smear, PSA — varies by age and sex, because active non-liver cancers are a contraindication), dental evaluation (dental infections can become life-threatening under immunosuppression), age-appropriate health screening, nutritional assessment (sarcopenia at transplant predicts worse outcomes — optimizing nutrition beforehand matters), and vaccination updates (live vaccines must be given before transplant, since immunosuppression afterward prevents their use).

Psychosocial evaluation

This assessment is equally important and sometimes the most challenging for patients. It evaluates your understanding of the transplant process, risks, and lifelong medication commitment, your support system (who will help you during recovery — transplant centers require a reliable caregiver for the first weeks), your mental health and emotional readiness, substance use history (particularly alcohol and drugs), compliance history with medical recommendations, financial and insurance considerations, and your ability to attend frequent follow-up appointments post-transplant.

The psychosocial evaluation is not about judging you. It's about identifying patients who need additional support and ensuring that the investment of a scarce organ has the best chance of a good outcome. If gaps are identified (depression, lack of support system, substance use concerns), transplant centers typically work with you to address them rather than simply declining your candidacy.

Selection committee review

After all evaluations are complete, your case is presented to the transplant center's multidisciplinary selection committee — hepatologists, surgeons, social workers, psychologists, and coordinators who collectively decide whether to list you. The committee may approve listing, request additional testing or interventions before listing (cardiac stent, dental work, weight loss, substance abuse treatment), or in some cases decline candidacy with specific reasons.

If you're approved, you're placed on the UNOS waiting list, and your MELD score determines your priority relative to other candidates.

What can disqualify you from transplant

Transplant centers must weigh whether a patient will survive the surgery and benefit long-term from receiving a scarce organ. The following are generally considered contraindications — though policies vary between centers, and some absolute contraindications at one center may be relative contraindications at another:

Absolute contraindications (generally disqualifying)

• Active cancer outside the liver — metastatic disease means the cancer will recur regardless of transplant

• Active, untreated infection (especially sepsis) — immunosuppression after transplant would be fatal

• Severe cardiopulmonary disease — if the heart or lungs can't survive the surgery, transplant isn't possible

• Irreversible brain damage

• Active alcohol or substance use — most centers require a period of documented abstinence (historically 6 months, though this is evolving — see below)

• Anatomic abnormalities that make surgery technically impossible

• AIDS with uncontrolled complications (well-controlled HIV is no longer a contraindication at many centers)

Relative contraindications (evaluated case by case)

• Advanced age — there's no absolute age cutoff at most centers, but patients over 70 undergo more rigorous evaluation of functional status and comorbidities

• Obesity — severe obesity (BMI >40) increases surgical risk. Some centers require weight loss before listing, others evaluate each case individually.

• Portal vein thrombosis — clotting in the portal vein makes surgery more complex but is not necessarily disqualifying

• Prior abdominal surgeries — increase technical complexity

• Poor social support or compliance history — transplant centers may require the patient to demonstrate improved compliance before listing

• Active psychiatric illness — if untreated and likely to prevent medication compliance post-transplant

The evolving alcohol policy

The traditional "6-month sobriety rule" — requiring patients with alcohol-related liver disease to demonstrate 6 months of abstinence before transplant listing — has been one of the most debated policies in transplant medicine. Multiple studies have shown that carefully selected patients with severe alcohol-related hepatitis who haven't completed 6 months of abstinence can have excellent post-transplant outcomes — comparable to patients transplanted for other indications.

As a result, many transplant centers have moved away from a rigid 6-month rule toward individualized assessment using validated tools (such as the SALT score and Stanford Integrated Psychosocial Assessment for Transplant) that predict the likelihood of return to harmful drinking post-transplant. The AASLD has formally acknowledged this shift. However, policies still vary significantly between centers — some maintain strict time-based requirements while others use a case-by-case approach.

If you or your loved one has alcohol-related liver disease, ask the transplant center specifically about their alcohol policy. Don't assume you're excluded.

MELD exception points: when the score doesn't tell the whole story

The MELD score is powerful but imperfect. Several conditions carry significant mortality risk that the MELD formula doesn't capture — because MELD only measures bilirubin, INR, creatinine, and sodium. For these conditions, the National Liver Review Board (NLRB) can grant MELD exception points that raise your effective score to reflect your true risk.

Conditions that commonly receive exception points include hepatocellular carcinoma (HCC) meeting Milan criteria — the most common exception. HCC patients often have relatively low MELD scores because their liver function is preserved, but their cancer risk justifies transplant priority. Hilar cholangiocarcinoma (after neoadjuvant chemoradiation, meeting specific size criteria), hepatopulmonary syndrome (liver disease causing abnormal blood vessel dilation in the lungs and low oxygen), portopulmonary hypertension (high blood pressure in the pulmonary arteries caused by portal hypertension), polycystic liver disease (when liver volume causes severe symptoms), familial amyloid polyneuropathy, and primary hyperoxaluria.

If your MELD score feels "too low" for how sick you are — and your transplant team agrees that your condition isn't adequately reflected by the score — they can submit an exception request to the NLRB. Read more about this: MELD Score Ranges Explained.

Living-donor liver transplant: the option most patients don't know about

In a living-donor liver transplant (LDLT), a healthy person — typically a family member, friend, or sometimes an altruistic stranger — donates a portion of their liver to the recipient. The liver is the only solid organ that regenerates: both the donor's remaining liver and the transplanted portion grow back to near-normal size within 6–8 weeks.

LDLT is a critically important option for several reasons. It eliminates the waiting list entirely — you don't need to wait for a deceased donor, which means transplant can happen before your condition deteriorates further. It can be scheduled electively, allowing optimal timing and preparation. The outcomes are excellent — comparable to deceased-donor transplant in experienced centers. And it's available regardless of MELD score — even patients with MELD below 15 who wouldn't receive a deceased-donor offer can receive a living-donor transplant.

Who can be a living donor?

Living donors must be between 18 and 60 years old at most centers, in excellent general health with no significant medical conditions, have a compatible blood type with the recipient, have adequate liver volume (assessed by imaging), pass comprehensive medical and psychological evaluation, and be acting voluntarily without coercion.

The donor surgery involves removing the right lobe (for adult-to-adult transplant) or left lobe (for adult-to-child), which represents roughly 50–60% of the liver. The donor typically spends 5–7 days in the hospital and returns to normal activities within 4–8 weeks. Donor mortality risk is approximately 0.1–0.3% — very low, but not zero. All potential donors are counseled extensively about risks before proceeding.

If you're on the waiting list with a MELD that's too low to receive a deceased-donor offer in your region, or if your condition is deteriorating and you can't afford to wait, LDLT may be your best option. Ask your transplant center about their living-donor program.

The referral threshold: when to start the conversation

Current guidelines recommend transplant referral when any of the following are present:

• MELD score of 15 or above

• Any decompensating event — first episode of ascites, variceal bleeding, or hepatic encephalopathy

• HCC within Milan criteria (or potentially downstageable to within criteria)

• Acute liver failure (emergency referral)

• Child-Pugh class B or C

The evaluation process takes months. Starting early — before you're in crisis — gives you more time for the workup, more options, and better outcomes. Patients who arrive at transplant centers after an emergency hospitalization have less time for optimization and may be too unstable for some evaluations.

If your hepatologist hasn't raised the transplant conversation and any of the above apply to you, it's appropriate to ask: "Should I be evaluated at a transplant center?"

What to do while waiting

The waiting period between listing and transplant is not passive. What you do during this time directly affects your outcomes:

• Keep your labs updated. Your MELD score is recalculated with each blood draw, and your position on the waiting list adjusts accordingly. Upload every lab report to LiverTracker and watch your trends.

• Maintain nutrition. Sarcopenia at the time of transplant independently predicts worse post-transplant survival. Eat 1.2–1.5 g/kg/day of protein. Don't skip your late-night snack. Don't restrict protein.

• Stay as physically active as possible. Even short walks preserve functional capacity.

• Manage complications aggressively. Sodium restriction for ascites, lactulose compliance for HE, beta-blockers for varices.

• Maintain absolute alcohol abstinence. Any alcohol use can jeopardize your candidacy.

• Stay in contact with your transplant coordinator. Report any new symptoms, hospitalizations, or changes in your condition.

• Keep your phone on and charged. The transplant call can come at any hour. Have a bag packed and a plan for getting to the hospital quickly.

• Share your LiverTracker data with your transplant team so they always have your most current information.

Post-transplant: the new beginning

Modern liver transplant outcomes are remarkable. Five-year survival after transplant is approximately 75–80%. Twenty-year survival exceeds 50%. Most transplant recipients report significantly improved quality of life compared to their pre-transplant state.

The commitment is lifelong: daily immunosuppressive medications (typically tacrolimus-based regimens) that prevent rejection, regular follow-up appointments (weekly initially, then monthly, then every few months), blood work monitoring (drug levels, liver function, kidney function), cancer screening (immunosuppression increases cancer risk), avoiding grapefruit (interferes with tacrolimus metabolism), and infection precautions (especially in the first year when immunosuppression is highest).

It's a new chapter — not without challenges, but for patients who were facing liver failure, it's the difference between dying and living.

Frequently asked questions

Is there an age limit for liver transplant?

Most centers don't have a hard age cutoff, but patients over 70 undergo more rigorous evaluation of their overall functional status, cardiac health, and expected life expectancy. Physiological age matters more than chronological age. Some centers have successfully transplanted patients in their late 70s who were otherwise healthy.

Can I get a transplant if I have alcohol-related liver disease?

Yes. Alcohol-related liver disease is now the leading indication for liver transplant in the United States. Most centers require a period of documented abstinence, though the rigid "6-month rule" has been replaced at many programs by individualized assessment using validated tools. Demonstrating commitment to sobriety — through treatment programs, counseling, and support groups — is essential. Ask your transplant center about their specific policy.

What if my MELD score is too low for transplant but I feel terrible?

MELD measures liver function through lab values — it doesn't capture quality of life, fatigue, encephalopathy severity, nutritional status, or many other factors that affect how you feel. If your symptoms are severe despite a "low" MELD, your transplant team can request exception points from the National Liver Review Board. Living-donor transplant is also an option regardless of MELD score.

How long is the waiting list?

Wait time varies enormously by region, blood type, and MELD score. In some regions, patients with MELD 30+ receive offers within weeks. In competitive urban centers, patients with MELD 20 may wait over a year. There are currently approximately 10,000–11,000 liver transplants performed annually in the US, with roughly 11,000–12,000 patients on the active waiting list at any given time. About 1,000–1,500 patients die or become too sick for transplant while waiting each year — which is why timely referral and living-donor options are so critical.

Can a family member donate part of their liver?

Yes — this is living-donor liver transplant. A healthy adult can donate a portion (typically the right lobe) of their liver, which regenerates to near-normal size in both the donor and recipient within 6–8 weeks. Donors must be 18–60 years old, in excellent health, with a compatible blood type. Donor mortality risk is approximately 0.1–0.3%. Many transplant centers have active living-donor programs — ask about this option early in your evaluation.

What happens after transplant?

Most patients spend 7–14 days in the hospital post-surgery, followed by frequent outpatient visits for the first few months. You'll take daily immunosuppressive medications (lifelong) to prevent rejection. Full recovery to normal activities typically takes 3–6 months. Five-year survival is approximately 75–80%, and most recipients report dramatically improved quality of life. You'll need ongoing monitoring — but for patients who were facing liver failure, transplant is transformative.

Medical references and sources

1. PMC. Selection for Liver Transplantation: Indications and Evaluation. 2020. PMC Full Text

2. Gastroenterology & Hepatology. Update on Organ Allocation and Liver Transplantation. July 2025. G&H

3. Hepatitis C Online (University of Washington). Liver Transplantation Referral. Updated 2026. HCV Online

4. UChicago Medicine. Understanding MELD for Liver Transplantation. UChicago

5. UNOS. Questions and Answers for Transplant Candidates about MELD and PELD. UNOS PDF

Related articles and tools on LiverTracker

• Understanding the Transplant Waiting List

• What Is MELD Score?

• MELD Score Ranges Explained

• Child-Pugh Score Explained

• Cirrhosis Stages Explained

• Living with Ascites

• Hepatic Encephalopathy Complete Guide

• Portal Hypertension and Varices

• Complete Guide to Liver Function Tests

• MELD Score Calculator

• Browse All Articles

Transplant isn't the end of the road — it's the bridge to a new one. Know your eligibility. Know your scores. And start the conversation before it becomes an emergency.

→ Calculate Your MELD Score Free

→ Start Tracking Free

→ Download the iOS App

Medical Disclaimer: This article is for informational and educational purposes only and is not a substitute for professional medical advice. Transplant eligibility criteria vary between centers. Always consult your hepatologist or transplant team for guidance specific to your condition. LiverTracker does not provide medical advice. For our complete disclaimer, visit livertracker.com/medical-disclaimer.